Related Experiment Video
Updated: Dec 12, 2025
09:01
Intraportal Transplantation of Pancreatic Islets in Mouse Model
Published on: May 5, 2018
10.0K
Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes
Khawla F Ali1, Betul Hatipoglu2
1Department of Medicine, Royal College of Surgeons in Ireland-Medical University of Bahrain, Bahrain.
OBM Transplantation
|August 11, 2020
Summary
Pancreatic islet transplantation shows promise for managing type 1 diabetes and preventing surgical diabetes. This review covers metabolic outcomes of both autologous and allogeneic islet transplantation, including recent findings.
Area of Science:
- Endocrinology and Metabolism
- Surgical Innovation
Background:
- Pancreatic islet transplantation is a key area in diabetes management.
- It offers solutions for type 1 diabetes and post-pancreatectomy hyperglycemia.
Purpose of the Study:
- To review the latest metabolic outcomes in islet transplantation.
- To highlight recent advancements in autologous islet transplantation.
Main Methods:
- Literature review of recent studies on islet transplantation outcomes.
- Analysis of institutional experience with autologous islet transplantation.
Main Results:
- Discusses metabolic improvements following both allogeneic and autologous islet transplantation.
- Presents current data on the effectiveness of these procedures.
Conclusions:
- Islet transplantation is a viable and evolving therapeutic option.
- Further research continues to refine outcomes for patients with diabetes.
